Kiniksa Pharmaceuticals International PLC (KNSA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -84.91 | -124.805 | -55.88 | -56.155 | -53.438 | -54.245 | 52.959 | 2.857 |
Return on Equity (%) | 186.328 | 112.393 | -108.913 | -64.145 | -60.065 | -63.554 | 63.1 | 3.373 |
Return on Invested Capital (%) | 186.479 | 113.004 | -115.181 | -67.402 | -61.655 | -65.107 | 96.201 | 3.198 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -406.131 | 5.008 | -6.161 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -409.724 | 83.279 | 5.211 |
Book Value Per Share | -3 | -10.46 | 2.821 | 2.118 | 2.811 | 1.2 | 2.711 | 3.001 |
Earnings Per Share | -2.795 | -7.564 | -1.043 | -1.521 | -1.454 | -1.143 | 1.315 | 0.1 |
Cash Per Share | 6.526 | 5.312 | 0.727 | 0.441 | 1.028 | 0.887 | 0.88 | 0.768 |
Working Capital Per Share | 6.3 | 3.46 | 2.74 | 2.009 | 2.716 | 1.098 | 1.406 | 1.513 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.213 | 1.415 | 1.686 |
EBIT Per Share | -2.791 | -7.564 | -1.045 | -1.54 | -1.408 | -1.133 | 0.079 | -0.119 |
EBITDA Per Share | -2.791 | -7.564 | -1.045 | -1.54 | -1.408 | -1.133 | 0.079 | -0.119 |
Free Cash Flow Per Share | -2.798 | -7.56 | -0.992 | -1.51 | -1.474 | -1.013 | 1.299 | 0.085 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 720k | 720k | 15,8M | 15,8M | 31,78M | 34,06M | 34,75M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 34,75M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -19.369 | N/A | N/A | N/A | -17.877 | N/A | N/A |
Net Profit Margin (%) | N/A | -25.38 | N/A | N/A | N/A | -22.169 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,46B |
Ratio cours/bénéfice | 104 |
Ratio prix/ventes | 5,42 |
Ratio prix/liquidités | 13,57 |
Ratio prix/valeur comptable | 3,34 |
Rendement de dividende | - |
Actions en circulation | 72,2M |
Volume moyen (1 semaine) | 887,11k |
Volume moyen (1 mois) | 689,5k |
Variation sur 52 semaines | 9,73% |
Plus haut sur 52 semaines | 28,15 |
Plus bas sur 52 semaines | 16,56 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales